Sign in to view content

The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections

Kapil Mishra, MD

Video
Published 2021

Related

COVID-19 Media Article Discussion of Gaslighting in New York Residencies, Debt Forgiveness Bill, and the Last Dance documentary
Jayanth Sridhar, MD
Member Podcasts
2020
Ranibizumab for Radiation Retinopathy (RRR) A Prospective, Multicenter Trial of Monthly Versus PRN Dosing for Radiation Retinopathy-Related Macular Edema
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2018
A Phase I Study to Evaluate the Tie2 Agonist RO7446603, Alone or in Combination With Aflibercept orFaricimab, in Diabetic Macular Edema
Jeremiah Brown, MD, MS, FASRS
Annual Meeting Talks
2025

Category: Socioeconomics

See more